Emerging Treatment Approaches and Multidisciplinary Management of Unresectable Stage III Non-Small Cell Lung Cancer - Episode 8
Exploring the Role of SBRT in Unresectable NSCLC: Patient Selection and Trial Insights
This segment explores the use of stereotactic body radiation therapy (SBRT) for treating small peripheral lesions in patients with lymph node–positive cancer, compared with conventional intensity-modulated radiation therapy. It discusses the potential advantages of SBRT in reducing treatment duration, its theoretical biological effects, and ongoing studies like the LU008 phase 3 trial.
Video content above is prompted by the following:
- Can you discuss the potential role of SBRT in unresectable non–small cell lung cancer (NSCLC) and any trials that can help guide decisions?
Related Content:
